Why Cronos Group's Partnership To Produce Cultured Cannabinoids Could Be A Big Deal

Earlier this month, Cronos Group, a vertically integrated Canadian marijuana company, entered into a partnership with Boston-based biotech startup Ginkgo Bioworks to develop cannabinoids using organism design and development technology.